A head patch device that delivers alternating electrical ... Developed by Jersey, US-based Novocure, Optune beams so-called Tumour Treating Fields (TTFs) through the scalp and into brain tumours ...

Marketed by Novocure, the Optune device consists of four inter-connected patches that cover the skull and deliver the company’s patented Tumour Treating Fields (TTFields). These electrical ...

Novocure’s device, Optune, was approved by the US Food and Drug Administration (FDA) in 2011 to treat recurrent glioblastoma multiforme (GBM), and in 2015 to treat newly diagnosed GBM in ...